biotech
Bio-AnalystSupplement research
person

Bacopa

Cognition

Partial research summary

Animal studies reported improvement in cognitive functions.

Single-ingredient studies · Scope not specified · Animal studies; human applicability unconfirmed · Includes patient groups · comparator not confirmed

Publications for this result: 2 (1 awaiting review included)

Other outcomes and study details

Distinct publications linked to this topic: 20

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Animal and cell findings are indirect evidence.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.

What has been studied?

Distinct human comparison papers: 2

  • Attention-Deficit

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      • Review
      • Systematic review
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: review summary across varied clinical trials; no common comparator estimate stated
  • choice reaction time

    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • Unspecified population
      • Secondary outcome
      • Between-group comparison
      • Study subject not identified
      • Timepoint: Chronic dosing of at least 12 weeks
      • Study comparison: Standardized Bacopa extract versus placebo in pooled trials
  • Cognitive flexibility

    • Comparison result:A better result than the comparison group was reported.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • cognitive functions

    Animal and cell research · indirect evidence
    • A change was reported in animal or cell research.
      Patient group · Single ingredient · 15 days
      Measurement and study conditions
      • Animal study · indirect
      • Single ingredient
      • Patient group
      • Primary outcome
      • Comparison unclear
      • Animal or cell research
      • Timepoint: 15 days
      • Study comparison: BM extract in colchicine-induced animal model; comparator details not specified in abstract
Other measured outcomes (6)
  • Letter Search and Stroop tasks

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      General population · Single ingredient · 1 and 2 hours after consumption
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • General population
      • Outcome role not specified
      • Within-group comparison
      • Timepoint: 1 and 2 hours after consumption
      • Study comparison: change from baseline after Bacopa extract; no stated placebo contrast
  • Memory free recall

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Single ingredient
      Measurement and study conditions
      • Review
      • Systematic review
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: unspecified
  • nootropic utility

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      General population · Single ingredient
      Measurement and study conditions
      • Review
      • Review
      • Single ingredient
      • General population
      • Secondary outcome
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: narrative review summary of human placebo-controlled trials and preclinical studies; no pooled estim
  • overall cognitive performance score

    • Comparison result:Results were mixed for this outcome.
      Patient group · Single ingredient · 1 and 2 months
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Primary outcome
      • Between-group comparison
      • Timepoint: 1 and 2 months
      • Study comparison: Bacopa vs placebo at three assessment time points
  • Trail B test

    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • Unspecified population
      • Secondary outcome
      • Between-group comparison
      • Study subject not identified
      • Timepoint: Chronic dosing of at least 12 weeks
      • Study comparison: Standardized Bacopa extract versus placebo in pooled trials
  • Working Memory

    Research with unclear study subject or type
    • The study reported improvement in this measurement.
      Single ingredient
      Measurement and study conditions
      • Review
      • Systematic review
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: unspecified

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (4)
  • cognitive impairment · Distinct papers needing additional review: 1Evidence criteria check: 1
  • cognitive performance · Distinct papers needing additional review: 1Direction unclear: 1
  • Memory · Distinct papers needing additional review: 1Direction unclear: 1
  • performance at the first, second, and fourth repetition post-dosing on the CDB · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Cognition

    Related papers 20 · human comparison papers 2

    View selected result
  • Stress and mood

    Related papers 2 · human comparison papers 1

    View results
    • self-reported stress reactivity · Improvement reported
  • Digestion and gut health

    Related papers 1 · human comparison papers 1

    View results
    • digestive complaints · Worsening reported
  • Immune and respiratory health

    Related papers 1 · comparison findings need further review

    View results
    • IL-1β, IL-6, COX-2, and iNOS · Animal or cell research · Comparison details unconfirmed
  • Sleep

    Related papers 1 · comparison findings need further review

    View results
    • sleep quality · Comparison details unconfirmed
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 60.3 evidence score includes 12 independent human studies and 11 clinical studies in the representative benefit area. The B tier reflects evidence directness, repetition, and consistency together.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 72

Papers linked to this topic 20 · distinct papers 20 · papers with a confirmed human comparison 2 · papers needing additional review 11

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Attention-Deficit: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • choice reaction time: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Cognitive flexibility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • cognitive functions: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • cognitive impairment: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • cognitive performance: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Letter Search and Stroop tasks: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Memory: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Memory free recall: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • nootropic utility: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • overall cognitive performance score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • performance at the first, second, and fourth repetition post-dosing on the CDB: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Trail B test: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Working Memory: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Cognition

What the research found

overall cognitive performance score

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cognitive flexibility

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Letter Search and Stroop tasks

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

choice reaction time

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Trail B test

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Working Memory

The study reported improvement in this measurement.

Review · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Attention-Deficit

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Memory free recall

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

nootropic utility

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · General population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive functions

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive functions

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive impairment

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

cognitive performance

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Memory

The study needs further checking before its result can be interpreted.

Review · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

performance at the first, second, and fourth repetition post-dosing on the CDB

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Separable contribution · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Review · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stress and mood

What the research found

self-reported stress reactivity

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Separable contribution · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Digestion and gut health

What the research found

digestive complaints

The study reported worsening in this measurement.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Immune and respiratory health

What the research found

IL-1β, IL-6, COX-2, and iNOS

A change was reported in animal or cell research.

Cell study · indirect · Single ingredient · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sleep

What the research found

sleep quality

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
1
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

Rey Auditory Verbal Learning Test (AVLT)1 papers
In a double-blind, placebo-controlled RCT, 300 mg/day Bacopa monnieri significantly improved verbal learning and memory acquisition in healthy older adults, though gastrointestinal side effects were reported.Human studies · Randomized controlled trial